[1]Siegel R L, Giaquinto A N, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.
[2]Eng C, Yoshino T, Ruíz-García E, et al. Colorectal cancer[J]. Lancet, 2024, 404(10449): 294-310.
[3]Jiang Y L, Liu Z, Xu F, et al. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer[J]. J Cell Mol Med, 2018, 22(10): 4875-4885.
[4]Hu W, Ding R S, Wang M Y, et al. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status[J]. Stem Cell Res Ther, 2023, 14(1): 145.
[5]Magalhães A, Duarte H O, Reis C A. The role of O-glycosylation in human disease[J]. Mol Aspects Med, 2021, 79: 100964.
[6]Harvey B M, Haltiwanger R S. Regulation of notch function by O-glycosylation[J]. Adv Exp Med Biol, 2018, 1066: 59-78.
[7]Sun X J, Zhan M R, Sun X, et al. C1GALT1 in health and disease[J]. Oncol Lett, 2021, 22(2): 589.
[8]Fang R P, Xu F F, Shi H, et al. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity[J]. Oncogene, 2020, 39(11): 2290-2304.
[9]van Tol W, Wessels H, Lefeber D J. O-glycosylation disorders pave the road for understanding the complex human O-glycosylation machinery[J]. Curr Opin Struct Biol, 2019, 56: 107-118.
[10]Zhou F N, Ma J, Zhu Y F, et al. The role and potential mechanism of O-glycosylation in gastrointestinal tumors[J]. Pharmacol Res, 2022, 184: 106420.
[11]Liu F, Fu J X, Bergstrom K, et al. Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer[J]. J Exp Med, 2020, 217(1): e20182325.
[12]Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes[J]. Proc Natl Acad Sci U S A, 2016, 113(8): E968-E977.
[13]Tkach M, Kowal J, Théry C. Why the need and how to approach the functional diversity of extracellular vesicles[J]. Philos Trans R Soc Lond B Biol Sci, 2018, 373(1737): 20160479.
[14]Gebert L F R, MacRae I J. Regulation of microRNA function in animals[J]. Nat Rev Mol Cell Biol, 2019, 20(1): 21-37.
[15]Rupaimoole R, Slack F J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov, 2017, 16(3): 203-222.
[16]Padda J, Khalid K, Khedr A, et al. Exosome-derived microRNA: efficacy in cancer[J]. Cureus, 2021, 13(8): e17441.
[17]Zhang J, Li S, Li L, et al. Exosome and exosomal MicroRNA: trafficking, sorting, and function[J]. Genomics Proteomics Bioinformatics, 2015, 13(1): 17-24.
[18]Weygant N, Ge Y, Qu D F, et al. Survival of patients with gastrointestinal cancers can be predicted by a surrogate microRNA signature for cancer stem-like cells marked by DCLK1 kinase[J]. Cancer Res, 2016, 76(14): 4090-4099.
[19]Fernández-Ponce C, Geribaldi-Doldán N, Sánchez-Gomar I, et al. The role of glycosyltransferases in colorectal cancer[J]. Int J Mol Sci, 2021, 22(11): 5822.
[20]Venkitachalam S, Guda K. Altered glycosyltransferases in colorectal cancer[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(1): 5-7.
[21]Liu Z, Liu J, Dong X C, et al. Tn antigen promotes human colorectal cancer metastasis via H-ras mediated epithelial-mesenchymal transition activation[J]. J Cell Mol Med, 2019, 23(3): 2083-2092.
[22]Kouri N M, Stangou M, Lioulios G, et al. Serum levels of miR-148b and let-7b at diagnosis may have important impact in the response to treatment and long-term outcome in IgA nephropathy[J]. J Clin Med, 2021, 10(9): 1987.
[23]Gallo A, Vella S, Tuzzolino F, et al. MicroRNA-mediated regulation of mucin-type O-glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren syndrome[J]. J Rheumatol, 2019, 46(11): 1485-1494.
[24]Li D N, Li Q. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis[J]. Bioengineered, 2022, 13(3): 6509-6520.
[25]Cava C, Novello C, Martelli C, et al. Theranostic application of miR-429 in HER2+ breast cancer[J]. Theranostics, 2020, 10(1): 50-61.
[26]Liu H, Huang C, Wu L Y, et al. Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer[J]. Onco Targets Ther, 2016, 9: 4121-4127.
[27]Peng P, Chen T, Wang Q, et al. Decreased miR-218-5p levels as a serum biomarker in bone metastasis of prostate cancer[J]. Oncol Res Treat, 2019, 42(4): 165-185.
[28]Miao C X, Zhang W L, Feng L X, et al. Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia[J]. Mol Ther Nucleic Acids, 2021, 24: 923-938.
[29]Zhang X, Liu Y, Huang W C, et al.MiR-125b-1-3p exerts antitumor functions in lung carcinoma cells by targeting S1PR1[J]. Chin Med J (Engl), 2018, 131(16): 1909-1916.
|